Predictive Biosciences | GenomeWeb

Predictive Biosciences

Agilent Technologies of Santa Clara, Calif., has received US Patent No.

NEW YORK (GenomeWeb News) – Predictive Biosciences will offer its molecular diagnostic bladder cancer tests to Arup Laboratories' national network of clients under a deal announced today.

Thermo Fisher Scientific has been awarded US Patent No. 8,378,115, "Monomethine dyes."
Charles Brush, Jianqin Liu, Peter Czerney, and Matthias Wenzel are named as inventors.

A team led by researchers at the University of Southern California and University of Miami has developed a nine-protein panel for predicting the progression of bladder cancer.

SISCAPA Assay Technologies this week appointed Gustavo Salem to its board of directors and hired Ian Wright as a consultant and primary architect of diagnostic business strategy.

This story was originally published June 22.

Applied Proteomics announced this week that it has appointed Peter Klemm as CEO and James Blair to its board of directors.

BG Medicine this week appointed Eric Bouvier as president and CEO. He replaces Pieter Muntendam, who has moved to the role of executive vice president and chief medical officer.

By Adam Bonislawski
With DNA-based affinity agents gaining prominence as tools for protein capture, scientists and biotech firms are exploring biomarker assays that simultaneously report both genetic and proteomic data.

According to the company's earnings statement, MDxHealth's product and service revenues nearly doubled – from €1 million in 2009 to €2 million in 2010 – due to several companion diagnostics deals and biomarker licensing agreements inked with major drug companies.

Pages

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.